Strain Information | |
---|---|
Image | |
BRC No. | RBRC02574 |
Type | Targeted Mutation |
Species | Mus musculus |
Strain name | B6;129P2-Phgdh<tm2Bsi> |
Former Common name | floxed allele |
H-2 Haplotype | |
ES Cell line | E14 [129P2/OlaHsd] |
Background strain | |
Appearance | |
Strain development | |
Strain description | |
Colony maintenance | |
References | J. Biol. Chem., 279, 3573-3577 (2004) 14645240 |
Health Report | |
---|---|
Examination Date / Room / Rack | 2024/01/22Room:3-CRack:K 2023/10/23Room:3-CRack:K 2023/07/24Room:3-CRack:K |
Gene | |
---|---|
Gene info | Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter Phgdh3-phosphoglycerate dehydrogenase3Phgdh<tm1.2Shfu>targeted mutation 1.2, Shigeki Furuya3-PGDH, 3PGDH, A10, PGAD, PGD, PGDH, SERA Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter loxPphage P1 loxP3loxP Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter loxPphage P1 loxP3loxP |
Ordering Information | |
---|---|
Donor DNA | Phage P1 loxP sites, mouse 3-Phosphoglycerate dehydrogenase (Phgdh)genomic DNA |
Research application | Cre/loxP system |
Specific Term and Conditions | The RECIPIENT of BIOLOGICAL RESOURCE shall obtain a prior written consent on use of it from the DEPOSITOR. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. J. Biol. Chem. 279, 3573-3577 (2004).1. The RECIPIENT agrees to use BIOLOGICAL RESOURCE only for academic research which is expected to be publicized in scientific papers. 2. The RECIPIENT will obtain a prior written consent on the use of BIOLOGICAL RESOURCE from the DEPOSITOR/DEVELOPER. At the same time, the RECIPIENT will give the DEPOSITOR/DEVELOPER the details of the research project using BIOLOGICAL RESOURCE for the DEPOSITOR/DEVELOPER to determine whether research collaboration is appropriate. 3. If the DEPOSITOR/DEVELOPER determines that the informed research project requires collaboration, a separate agreement will be formulated by both parties to establish rules such as handling of the research results. 4. If the DEPOSITOR/DEVELOPER determines that the informed research project does not require collaboration, the RECIPIENT agrees to cite the literature(s) designated by the DEPOSITOR/DEVELOPER when publicizing the research results obtained from use of BIOLOGICAL RESOURCE, and to discuss with the DEPOSITOR/DEVELOPER when application for any patents is considered. 5. If the RECIPIENT wants to crossbreed BIOLOGICAL RESOURCE with other genetically engineered mice, the RECIPIENT will obtain a prior written consent from the DEPOSITOR/DEVELOPER. 6. The RECIPIENT will not distribute the BIOLOGICAL RESOURCE to any other individual or entity. |
Depositor | Yoshio Hirabayashi (RIKEN) |
Strain Status | Frozen embryos Frozen sperm |
Strain Availability | Recovered litters from cryopreserved embryos (2 to 4 months) Cryopreserved sperm (within 1 month) Cryopreserved embryos (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
No Data |